Predictors of Contrast Induced Nephropathy in Patients with STEMI

Abstract

Get full access to this article

View all access options for this article.

References

Şaylık

Çınar

Akbulut

, et al. Serum Uric acid to albumin ratio can predict contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Angiology. 2024;75:398-399.

Frangogiannis

. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5:1841-1875.

Shah

Claggett

Prasad

, et al. Impact of Sacubitril/Valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction: The PARADISE-MI echocardiographic substudy. Circulation. 2022;146:1067-1081.

Lin

Dong

Liu

, et al. Renal safety and renin-angiotensin-aldosterone system inhibitors in patients with contrast media exposure: A multicenter randomized controlled study. J Cardiovasc Pharmacol. 2022;80:718-724.

Zhou

Zhang

, et al. Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction. J Int Med Res. 2023;51:3000605231182547.

Golshani

Tavasoli

Farsavian

, et al. Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin. J Family Med Prim Care. 2022;11:1957-1962.

Karagkounis

. Cardiac and renal effects of sodium-glucose co-transporter 2 inhibitors. Drug Ther Bull. 2023;61:103-107.

Paolisso

Bergamaschi

Cesaro

, et al. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry. Diabetes Res Clin Pract. 2023;202:110766.